Navigating the Broad Implications of EKRA in the Substance Abuse and Diagnostic Laboratory Testing Industries
Posted on Fraud Investigation, Health Care Law News July 19, 2022 by Rachel Broughton

The Eliminating Kickbacks in Recovery Act, otherwise known as EKRA, is a fairly new federal law that targets patient brokering and recovery profiteering. EKRA broadly makes it a federal crime for anyone, with respect to services covered by any health care benefit program, to knowingly and willfully: solicit or receive any remuneration (including any kickback, Read more →